HER2-Positive Breast Cancer Treatment
The FDA has approved a number of targeted therapies to treat HER2-positive breast cancer, including: Trastuzumab (Herceptin) has been approved to be used to prevent a relapse in patients with…
The FDA has approved a number of targeted therapies to treat HER2-positive breast cancer, including: Trastuzumab (Herceptin) has been approved to be used to prevent a relapse in patients with…